A new generation of Coonawarra winemakers is making premium reds to drink earlier, without losing the region’s global ...

Barrenjoey has lifted its price targets on a host of gold stocks with prices continuing to rise, suggesting ASX names still have big upside.

It’s no easy gig analysing share prices and company performance but somebody’s got to do it. Every week two experts give us ...

The mineral sands market might have stalled but punters are still rewarding companies that are pushing their projects towards development.

BHP has run headlong into a dispute with a powerful Chinese iron ore buyer, but the impact is yet to be felt on the ASX or iron ore prices.

There are plenty of positive indications that the acquisition of the high-grade Shafter silver project in Texas is a winning ...

The ASX did a solid job to close out the week, even as oil spilt and gold weighed (for a change). Techies were plugged in, ...

After five months of consecutive gains the ASX 200 fell 0.78% in September with nine of 11 sectors in the red.

With the top-end stocks looking unexciting and overloved, investors have turned to the oft-maligned small caps sector for value.

Success in a ballot has given CGN Resources two tenements along strike from multi-million-ounce gold deposits in WA’s Leonora region.

Morgans' senior healthcare analyst Scott Power is optimistic as ASX health stocks make a much-needed resurgence this week.

Known for its nasal spray offering rapid onset to treat ED, LTR Pharma is expanding its portfolio while aiming for a swift ride to market.